Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Regulatory T cells (T(R)) mediate peripheral immunological tolerance and are implicated in tumor progression. Because prostate cancer is being investigated for treatment by immunotherapy, we have assessed tumor T(R) in prostate cancers. METHODS: T(R) cells were identified by FOXP3 in tissue microarrays (TMAs) from 146 radical prostatectomies and correlated with clinicopathological tumor parameters and prostatic specific antigen rise (PSA). RESULTS: Twenty of 146 tumors contained no T(R). The mean of the average for the remaining 146 patients was 7.24. There was a significant correlation between T(R) and androgen receptor (P=0.003) and with hypoxia-inducible factor (HIF)-2alpha (P=0.007) but not HIF-1alpha (P=0.25). There was no significant correlation between T(R) numbers and stage, capsular invasion, urethral margins, vascular invasion, Gleason score, pre-operative PSA, or time to PSA recurrence (all P>0.05). CONCLUSIONS: T(R) in prostate tumors shows significant heterogeneity and may be the result of hormonal and hypoxic signaling. Targeting these may reduce T(R) in tumors allowing more successful immune therapies.

Original publication

DOI

10.1002/pros.20538

Type

Journal article

Journal

Prostate

Publication Date

01/05/2007

Volume

67

Pages

623 - 629

Keywords

Adenocarcinoma, Adult, Aged, Basic Helix-Loop-Helix Transcription Factors, Biomarkers, Tumor, Cell Count, Forkhead Transcription Factors, Humans, Hypoxia-Inducible Factor 1, alpha Subunit, Male, Middle Aged, Neoplasm Proteins, Neoplasm Recurrence, Local, Prostate, Prostate-Specific Antigen, Prostatic Neoplasms, Receptors, Androgen, Retrospective Studies, T-Lymphocytes, Regulatory, Tissue Array Analysis, Transcription Factors